FiercePharma· @FiercePharma · X·· 28 天前精选AI 评分58
AI 导读
Veradermics宣布其口服脱发治疗药物缓释米诺地尔制剂在一项3期试验中于全部主要和次要终点优于安慰剂,这是该疗法又一次3期试验胜利。原文未披露具体疗效数据。
推荐理由
该口服脱发疗法在3期试验中于全部主要和次要终点优于安慰剂,可观察缓释米诺地尔口服剂型的研发进展。
正文
Veradermics has scored another phase 3 win for its oral hair loss treatment, with the extended-release minoxidil formulation beating placebo on all primary and secondary endpoints. https://www.fiercepharma.com/pharma/veradermics-hot-streak-continue-another-phase-3-win-against-hair-loss
来源:FiercePharma · x.com